viatris website


You can access Pfizer's, Mylan's and Newco's filings with the SEC through the SEC website at www.sec.gov or through Pfizer's or Mylan's website, as applicable, and Pfizer and Mylan strongly encourage you to do so. Melissa Trombetta +1 (724) 514-1813 About UpjohnWith over 130 years of experience in improving patient lives, Pfizer Upjohn seeks to leverage our portfolio, global experience and expertise to become the trusted partner of choice for all stakeholders committed to improving patient health. Upjohn's network of approximately 11,500 colleagues works together to be fast, focused and flexible to ensure that patients around the world access the healthcare they need.

We market our products in more than 165 countries and territories. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. Pfizer Investor Relations:

Learn more Mylan has a portfolio of 7,500+ marketed products. Logo. Mylan Media Relations: These documents (when they are available) can also be obtained free of charge from Mylan, upon written request to Mylan, at (724) 514-1813 or investor.relations@mylan.com or from Pfizer on Pfizer’s internet website at https://investors.Pfizer.com/financials/sec-filings/default.aspx or by contacting Pfizer’s Investor Relations Department at (212) 733-2323, as applicable. Ryan Crowe +1 (212) 733-8160 Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. We focus on relieving the burden of non-communicable diseases with trusted, quality medicines for every patient, everywhere, with the goal of treating 225 million new patients by 2025. Cloudflare Ray ID: 5e305442fd9a2b22 Except as required by applicable law, Pfizer, Mylan and Newco undertake no obligation to update any statements herein for revisions or changes after these communications are made. Factors that could cause or contribute to such differences include, but are not limited to: the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction; changes in relevant tax and other laws; the parties’ ability to consummate the proposed transaction; the conditions to the completion of the proposed transaction, including receipt of approval of Mylan’s shareholders, not being satisfied or waived on the anticipated timeframe or at all; the regulatory approvals required for the proposed transaction not being obtained on the terms expected or on the anticipated schedule or at all; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with accounting principles generally accepted in the United States of America and related standards or on an adjusted basis; the integration of Mylan and Newco being more difficult, time consuming or costly than expected; Mylan’s, the Upjohn Business’s and the combined company’s failure to achieve expected or targeted future financial and operating performance and results; the possibility that the combined company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the proposed transaction within the expected time frames or at all or to successfully integrate Mylan and Newco; customer loss and business disruption being greater than expected following the proposed transaction; the retention of key employees being more difficult following the proposed transaction; any regulatory, legal or other impediments to Mylan’s, the Upjohn Business’s or the combined company’s ability to bring new products to market, including but not limited to where Mylan, the Upjohn Business or the combined company uses its business judgment and decides to manufacture, market and/or sell products, directly or through third parties, notwithstanding the fact that allegations of patent infringement(s) have not been finally resolved by the courts (i.e., an “at-risk launch”); success of clinical trials and Mylan’s, the Upjohn Business’s or the combined company’s ability to execute on new product opportunities; any changes in or difficulties with Mylan’s, the Upjohn Business’s or the combined company’s manufacturing facilities, including with respect to remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; the scope, timing and outcome of any ongoing legal proceedings, including government investigations, and the impact of any such proceedings on Mylan’s, the Upjohn Business’s or the combined company’s consolidated financial condition, results of operations and/or cash flows; Mylan’s, the Upjohn Business’s and the combined company’s ability to protect their respective intellectual property and preserve their respective intellectual property rights; the effect of any changes in customer and supplier relationships and customer purchasing patterns; the ability to attract and retain key personnel; changes in third-party relationships; actions and decisions of healthcare and pharmaceutical regulators; the impacts of competition; changes in the economic and financial conditions of the Upjohn Business or the business of Mylan or the combined company; uncertainties regarding future demand, pricing and reimbursement for our, the Upjohn Business’s or the combined company’s products; and uncertainties and matters beyond the control of management and other factors described under “Risk Factors” in each of Pfizer’s and Mylan’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission (“SEC”).

Black And White Movie 2019, Zeke Young, Marco Rojas, Tim Donnelly Wikipedia, Peter Pan 2020, Andrew Wilkinson Metalab, Ocad University Acceptance Rate, Gunsmoke Cast Salaries, Retiring In New Zealand, Future Wars, Arthrex Products, Melbourne Cbd Area, Ridiculously Funny Factsdrake So Far Gone Review, Jackson Rathbone Instagram, Bulletproof 360, Henry Tadeusz Farrell, Ander Herrera Salary Weekly, Rise Of Nations, Jets 2020 Opponents, Livescore Cz, The Soul Of A New Machine, Germany Vs Uk Comparison, Power Outage San Francisco Today, West End Brewery Contact, August Mcgregor Net Worth, Canterbury Tales 3, Copa America 2019 Qualifiers, Craig Stott Instagram, Victoria Bitter, Holding The Man Full Movie 123movies, Earthquake On Land, Alvin Roblox, The Running Man Characters, Interactive Reading Logs, 1080p Video Doorbell, The House Elf (2019 Full Movie), Splash Mountain Ride, Arnold Schwarzenegger Height, Second Breath, Thomas Lemar, Dance Like This, Superclásico Football, Nest Doorbell Cheap, Is Baby Driver On Netflix 2020, Millennium Dome Structure, Joe Meek Discography, Ring Windows 10 App, I Feel Fine Lyrics, Wildebeest Facts, Sam Ellis Track, Globe Theatre View From My Seat, Cardinal Health Warehouse Locations, Abbott Baddi, Skechers Shoes, Characteristics Of Culture, Baxter Financials, Tim Donnelly Actor Height, Alexandru Silviu Banica, Jeremy Spencer Fleetwood, Thoratec Pleasanton, Population Of Canada 2020, Fresh Prince Of Bel Air Instrumental, Mylan Pfizer Merger Latest News, Marcia Aoki, Alice In Wonderland Epub, Teddy Schwarzman Movies, Sergei Fedorov, Facts About Australian Culture, Nioh 2 Dlc 2 Release Date, M1 Tank Platoon II, Virgin Media Broadband Ireland, Vietnam Tunnel Rats Stories, Four Brothers Pizza, Order Home Cooked Meals, Peter Weller Net Worth, Joshua Buatsi Fight, Toronto Maple Leafs Logo Png, Reiss Nelson Girlfriend, Remote Control Pc, Russia Vs United States Size, Opinion En Anglais, Is Social Media Good Or Bad For Students,